您的位置：首页 > 产品中心 > 169437-35-8， 16:0-18:1 PA
16:0-18:1 PA
| 产品编号： | 4095329 |
| 规格： | 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphate (sodium salt), powder |
| CAS NO： | 169437-35-8 |
| 包装规格： | 25 MG，200 MG，500 MG |
| 产品类别： | 进口试剂 |
| 品牌： | Avanti |
| 优惠价： | 立即咨询 |
产品价格查看更多规格...
| 产品编号 | 包装单位 | 单价(元) | 国内现货 | 国外库存 | 询价单 |
| 4095329 | 25 MG | 1078 | |||
| 4095329 | 200 MG | 3090 | |||
| 4095329 | 500 MG | 5010 |
产品别名
169437-35-8
16:0-18:1 PA
1-hexadecanoyl-2--(9Z-octadecenoyl)-sn-glycero-3-phosphate (sodium salt); POPA; PA(16:0/18:1(9Z)); 110616
结构式
基本信息
| Empirical Formula【经验(实验)分子式】 | C37H70O8PNa |
| Molecular weight | 696.91 |
| NACRES | NA.25 |
| General description【一般描述】 | Phosphatidic acid (PA), the smallest and simplest phospholipid is produced from phosphatidylcholine with the help of phospholipase D. This glycerophospholipid is an ester of glycerol, which possess two long-chain fatty acids (LCFAs) at C1 and C2 and phosphoric acid at C3 positions. |
| Application【应用】 | 16:0-18:1 PA is suitable for use
|
| Biochem/physiol Actions【生化/生理作用】 | Phosphatidic acid (PA) may induce negative curvature in the cytoplasmic leaflet of the plasma membrane, which enables the development of the hemi fusion intermediates, that is essential for the fusion of two membranes. |
产品性质
| Assay【测定】 | >99% (TLC) |
| form【形式】 | powder |
| manufacturer/tradename | Avanti Polar Lipids 840857P |
| shipped in【运输】 | dry ice |
| storage temp.【储存温度】 | −20℃ |
| SMILES string | [H][C@@](COP([O-])(O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+] |
| packaging【包装】 | 5 mL Clear Glass Sealed Ampule (840857P-500mg) 5 mL Clear Glass Sealed Ampule (840857P-200mg) 5 mL Clear Glass Sealed Ampule (840857P-25mg) |
安全信息
| Storage Class Code【储存分类代码】 | 11 - Combustible Solids |
| WGK | WGK 3 |
